Blood Stream Infection Testing Market Forecasts to 2028 – Global Analysis By Technology (Molecular, Culture-Based, Proteomic), Product (Instruments, Consumables, Software), Application (Fungemia, Bacteremia) and By Geography
According to Stratistics MRC, the Global Blood Stream Infection Testing Market is accounted for $4,407.00 million in 2020 and is expected to reach $9,725.14 million by 2028 growing at a CAGR of 10.4% during the forecast period. Surging cases of sepsis and increasing occurrence of infectious ailments, and advancement in healthcare technology are driving the market growth. However, high costs involved in diagnosis and absence of medical compensation are hampering the growth of the market.
Blood stream infection is a condition in which bacterial, fungal, or any infection is detected in the blood. These infections are frequent and life-threatening in hospital settings. Bloodstream infection testing is an in-vitro diagnostic technique used for detecting the presence of foreign bodies such as bacteria, yeast, and/or fungus in the blood of an individual.
Based on the product, the instruments segment is going to have lucrative growth during the forecast period as automated instruments are more efficient and provide reliable results in a short time. Moreover, with the help of these instruments the results are more reproducible and operational errors are reduced thereby fueling the demand for segment. By geography, North America is going to have high growth during the forecast period due to factors such as high infection rate, increase in awareness, high diagnosis rate, favorable medical reimbursement scenario, and developed medical facilities in this region.
Some of the key players profiled in the Blood Stream Infection Testing Market include Abbott Laboratories, Accelerate Diagnostics Inc, Beckman Coulter Inc, Becton, Dickinson And Company, Biomérieux Inc., Cepheid Inc, Danaher Corp, F. Hoffmann-La Roche AG, Siemens Healthcare and Thermo Fisher Scientific Inc.
Estimated Market Size in 2020:
USD 4,407.00 million
Compound Annual Growth Rate (CAGR) from 2020 to 2028:
Predicted 2028 Value:
USD 9,725.14 million
Tables, Graphs & Figures
Product, Test Type, Technology, Technique,
Application, End User and Region
Core Drivers and Opportunities:
Restraining Factors & Market Threats:
• Consumables (Reagents)
• Software & Services
Test Types Covered:
• Conventional Blood Culture Tests
• Blood Gases
• Complete Blood Count (CBC)
• Culture of Skin Sore
• Cerebrospinal Fluid (CSF) Culture
• Platelet Count
• Urine Culture
• Chest X-Ray
• Polymerase Chain Reaction (PCR) Method
• Nucleic Acid Testing
• Mass Spectroscopy
• Point-of-Care Testing
• Clotting Studies
• Non-Conventional Testing
• Conventional Testing
End Users Covered:
• Hospital Laboratories
• Academic Research Laboratories
• Reference Laboratories
• Independent Research & Diagnostic Centers
• Other End Users
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Key Questions Answered In The Report
The Global Blood Stream Infection Testing Market is majorly driven by surging cases of sepsis and increasing occurrence of infectious ailments, and advancement in healthcare technology.
The instruments segment is growing at a highest CAGR as automated instruments are more efficient and provide reliable results in a short time. Moreover, with the help of these instruments the results are more reproducible.
North America dominated with a significant market share due to the factors such as high infection rate, increase in awareness, high diagnosis rate, favorable medical reimbursement scenario, and developed medical facilities in this region.
Asia Pacific market is growing at a highest CAGR owing to high prevalence of chronic diseases in the region and wide availability of innovative products offering better solutions to patients.
Key players in Blood Stream Infection Testing Market include Abbott Laboratories, Accelerate Diagnostics Inc, Beckman Coulter Inc, Becton, Dickinson And Company, Biomérieux Inc., Cepheid Inc, Danaher Corp, F. Hoffmann-La Roche AG, Siemens Healthcare and Thermo Fisher Scientific Inc.
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.